Meropenem Infusion Protocol for 60 kg Elderly Male with Urosepsis
For a 60 kg elderly male with urosepsis, administer meropenem 1 gram intravenously every 8 hours as a 30-minute infusion. 1
Dosing Considerations
Standard Dosing
- For urosepsis (intra-abdominal infection): 1 gram IV every 8 hours 1
- Standard infusion time: 15-30 minutes 1
- Alternative administration: Extended infusion over 3 hours may improve efficacy for severe infections 2
Age-Related Adjustments
- For patients >59 years old: Consider reducing dose to 10 mg/kg (600 mg) if renal function is compromised 3
- However, for severe infections like urosepsis, maintaining the full dose of 1 gram is recommended if renal function is normal 1
Infusion Rate Calculation
Standard 30-minute Infusion (Recommended)
- Meropenem 1 gram is typically diluted in 100 mL of compatible solution
- Infusion rate: 100 mL ÷ 30 minutes = 200 mL/hour
Extended 3-hour Infusion (Alternative for severe infections)
- Meropenem 1 gram diluted in 100 mL
- Infusion rate: 100 mL ÷ 180 minutes = 33.3 mL/hour
Renal Function Considerations
If the patient has renal impairment, adjust dosing based on creatinine clearance:
| Creatinine Clearance (mL/min) | Dose | Dosing Interval | Infusion Rate (mL/hr) for 30-min infusion |
|---|---|---|---|
| >50 | 1 g | Every 8 hours | 200 mL/hour |
| 26-50 | 1 g | Every 12 hours | 200 mL/hour |
| 10-25 | 0.5 g | Every 12 hours | 100 mL/hour |
| <10 | 0.5 g | Every 24 hours | 100 mL/hour |
Clinical Considerations
Pharmacokinetic/Pharmacodynamic Targets
- Efficacy of beta-lactams like meropenem depends on time above MIC (T>MIC)
- Standard dosing achieves adequate T>MIC for most susceptible pathogens
- Extended infusion may be beneficial for:
Duration of Therapy
- For urosepsis: 7-14 days of therapy is typically recommended 2
- Consider shorter duration (5-7 days) if rapid clinical improvement occurs 2
Monitoring
- Monitor renal function regularly during therapy
- Assess clinical response (temperature, heart rate, blood pressure, respiratory rate)
- Consider therapeutic drug monitoring in critically ill patients if available 3
Special Considerations
Critically Ill Patients
- Loading dose may be beneficial in critically ill patients with sepsis 3
- Extended or continuous infusion improves target attainment in critically ill patients 4
- For septic shock, combination therapy may be considered initially, then de-escalate based on culture results 3
Common Pitfalls to Avoid
- Failing to adjust dose in renal impairment
- Using standard infusion for difficult-to-treat infections when extended infusion may be more effective
- Not reassessing therapy based on culture results and clinical response
- Inadequate duration of therapy for complicated infections
By following this protocol, you can optimize meropenem therapy for this elderly patient with urosepsis, ensuring adequate drug exposure while minimizing potential toxicity.